Company

ALX Oncology

Biotechnology Research South San Francisco, California, United States 73 employees ALXO

Employees: 73
Contacts: 3
Emails: 3
Phones: 2

alxoncology.com LinkedIn

ALX Oncology Overview

Headquarters: South San Francisco, California, United States
Website: alxoncology.com
Industry: Biotechnology Research
Employees: 73
Founded: 2015
Stock Symbol: ALXO
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Immuno-Oncology Novel Biologics Research and Development Innovation CD47

About ALX Oncology

ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.

ALX Oncology Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

ALX Oncology Org Chart

Sample employees and titles

Name	Title	Location	Contact
Harish Shantharam, Cfa		San Mateo, California, United States	Email
Rekha Hemrajani		San Francisco Bay Area, United States	Email Phone
Julie Bacon		Edmonds, Washington, United States	View
Nathan Pofahl	Learning Leader	Vacaville, California, United States	Email Phone